BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 3:33:08 AM | Browse: 154 | Download: 406
 |
Received |
|
2025-06-17 10:17 |
|
Peer-Review Started |
|
2025-06-17 10:19 |
|
First Decision by Editorial Office Director |
|
2025-07-24 08:36 |
|
Return for Revision |
|
2025-07-24 08:36 |
|
Revised |
|
2025-08-01 03:47 |
|
Publication Fee Transferred |
|
2025-08-03 07:24 |
|
Second Decision by Editor |
|
2025-08-28 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-08-28 06:47 |
|
Articles in Press |
|
2025-08-28 06:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-08 07:59 |
|
Publish the Manuscript Online |
|
2025-09-25 03:33 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Supatsri Sethasine, Padoemwut Teerawongsakul, Witchakorn Ruamtawee, Nutachat Treerasoradaj and Huttakan Navadurong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Huttakan Navadurong, Lecturer, MD, Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, 681 Samsen Road, Bangkok 10300, Thailand. huttakan.nav@nmu.ac.th |
| Key Words |
Albumin-bilirubin; Metabolic-associated steatotic liver disease; Survival; Hepatic outcomes; Risk prediction |
| Core Tip |
The albumin-bilirubin (ALBI) score, which was developed for hepatocellular carcinoma, showed a strong predictive value for long-term liver-related complications and all-cause mortality in patients with metabolic-associated steatotic liver disease (MASLD). In a cohort of 1163 patients with MASLD, ALBI outperformed fibrosis-4 and the existing prognostic models. Incorporating ALBI significantly improved the predictive accuracy for long-term complications and mortality, suggesting its potential role as a valuable and noninvasive tool for long-term risk stratification in MASLD. |
| Publish Date |
2025-09-25 03:33 |
| Citation |
Sethasine S, Teerawongsakul P, Ruamtawee W, Treerasoradaj N, Navadurong H. Added value of the albumin-bilirubin score in predicting liver-related complications and mortality in metabolic-associated steatotic liver disease. World J Gastroenterol 2025; 31(37): 110829 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i37/110829.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i37.110829 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
